Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14251 - 14275 of 14740 in total
LY518674 has been used in trials studying the treatment of Metabolic Syndrome X.
Investigational
Experimental
Experimental
Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis that is currently undergoing phase II clinical testing in eight European countries.
Investigational
Spiradoline has been investigated for the basic science of Bipolar Depression.
Investigational
Netoglitazone (MCC-555) is a hypoglycemic agent.
Experimental
Displaying drugs 14251 - 14275 of 14740 in total